Oppenheimer Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-40,311
| Closed | -$585K | – | 1169 |
|
|
2022
Q4 | $585K | Sell |
40,311
-8,374
| -17% | -$122K | 0.01% | 809 |
|
|
2022
Q3 | $929K | Buy |
48,685
+1,694
| +4% | +$32.3K | 0.02% | 673 |
|
|
2022
Q2 | $854K | Sell |
46,991
-2,986
| -6% | -$54.3K | 0.01% | 720 |
|
|
2022
Q1 | $1.26M | Buy |
49,977
+687
| +1% | +$17.3K | 0.02% | 673 |
|
|
2021
Q4 | $1.36M | Sell |
49,290
-1,329
| -3% | -$36.7K | 0.02% | 680 |
|
|
2021
Q3 | $1.63M | Buy |
50,619
+233
| +0.5% | +$7.52K | 0.02% | 596 |
|
|
2021
Q2 | $1.54M | Sell |
50,386
-11,283
| -18% | -$345K | 0.02% | 615 |
|
|
2021
Q1 | $1.88M | Buy |
61,669
+5,889
| +11% | +$179K | 0.03% | 531 |
|
|
2020
Q4 | $1.1M | Buy |
55,780
+8,866
| +19% | +$175K | 0.02% | 663 |
|
|
2020
Q3 | $612K | Sell |
46,914
-1,474
| -3% | -$19.2K | 0.01% | 764 |
|
|
2020
Q2 | $549K | Sell |
48,388
-1,279
| -3% | -$14.5K | 0.01% | 777 |
|
|
2020
Q1 | $711K | Buy |
49,667
+2,168
| +5% | +$31K | 0.02% | 645 |
|
|
2019
Q4 | $1.29M | Sell |
47,499
-4,111
| -8% | -$112K | 0.03% | 558 |
|
|
2019
Q3 | $1.48M | Buy |
+51,610
| New | +$1.48M | 0.03% | 490 |
|